Moreno, Rui
Rhodes, Andrew
Piquilloud, Lise
Hernandez, Glenn
Takala, Jukka
Gershengorn, Hayley B.
Tavares, Miguel
Coopersmith, Craig M.
Myatra, Sheila N.
Singer, Mervyn
Rezende, Ederlon
Prescott, Hallie C.
Soares, Márcio
Timsit, Jean-François
de Lange, Dylan W.
Jung, Christian
De Waele, Jan J.
Martin, Greg S.
Summers, Charlotte
Azoulay, Elie
Fujii, Tomoko
McLean, Anthony S.
Vincent, Jean-Louis
Article History
Received: 19 September 2022
Accepted: 20 December 2022
First Online: 13 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: RM has no competing interest to declare relevant to this article. AR has no competing interest to declare relevant to this article. LP has no competing interest to declare relevant to this article. GH has no competing interest to declare relevant to this article. JT has no competing interest to declare relevant to this article. HBG received funding from Gilead Sciences, Inc. to serve on COVID therapeutics advisory board (not related to this work). MT has no competing interest to declare relevant to this article. CMC is an Associate Editor of <i>Critical Care</i>—he has no other competing interest to declare relevant to this article. SNM has no competing interest to declare relevant to this article. Mervyn S has no competing interest to declare relevant to this article. ER has no competing interest to declare relevant to this article. HCP served on the surviving sepsis campaign guidelines and is physician-lead for a Michigan statewide sepsis consortium. This manuscript does not represent the views of the Department of Veterans Affairs or the US government. This material is the result of work supported with resources and use of facilities at the Ann Arbor VA Medical Center. Marcio S is founder and equity shareholder of Epimed Solutions®, which commercializes the Epimed Monitor System<sup>®</sup>, a cloud-based software for ICU management and benchmarking. JFT has no competing interest to declare relevant to this article. DWdL has no competing interest to declare relevant to this article. CJ has no competing interest to declare relevant to this article. JJDW has no competing interest to declare relevant to this article. GSM has no competing interest to declare relevant to this article. CS has no competing interest to declare relevant to this article. EA has no competing interest to declare relevant to this article. AR has no competing interest to declare relevant to this article. TF has no competing interest to declare relevant to this article. ASM has no competing interest to declare relevant to this article. JLV is Editor-in-Chief of <i>Critical Care</i>—he has no other competing interest to declare relevant to this article.